Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526159 | 0.88 | KMT2A (0.59) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL6029698 | 0.86 | KMT2A (0.52) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL3457566 | 0.84 | S1PR3 (0.40) | KMT2AMEN1 | |
| SCHEMBL6030503 | 0.83 | KMT2A (0.53) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL6030604 | 0.83 | KMT2A (0.53) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL6553866 | 0.81 | LMNA (0.60) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL16240114 | 0.81 | KMT2A (0.53) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL27618514 | 0.79 | KMT2A (0.51) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL27637680 | 0.77 | KMT2A (0.52) | KMT2AMAPK1GAASMN1; SMN2LMNA | |
| SCHEMBL7165657 | 0.75 | KMT2A (0.49) | KMT2AMAPK1GAASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1484970-B1 | BENZAMIDES AND COMPOSITIONS COMPRISING BENZAMIDES FOR USE AS FUNGICIDES | DU PONT (US) | 2013-06-26 | — | — | EP | claimed |
| EP-2260704-B1 | Fungicidal compositions comprising a benzamide and cymoxanil | DU PONT (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-1484970-B1 | BENZAMIDES AND COMPOSITIONS COMPRISING BENZAMIDES FOR USE AS FUNGICIDES | DU PONT (US) | 2013-06-26 | — | — | EP | disclosed |
| EP-2260705-A2 | Fungicidal compositions comprising a benzamide and a michondrial respiration inhibitor | E. I. du Pont de Nemours and Company (US) | 2010-12-15 | — | — | EP | disclosed |
| EP-2260703-A2 | Fungicidal compositions comprising a benzamide and fosetyl-aluminium | E. I. du Pont de Nemours and Company (US) | 2010-12-15 | — | — | EP | disclosed |
| EP-2260704-A2 | Fungicidal compositions comprising a benzamide and cymoxanil | E. I. du Pont de Nemours and Company (US) | 2010-12-15 | — | — | EP | disclosed |
| US-20050164999-A1 | Benzamides and compositions benzamides for use as fungicizide | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050164999-A1 | Benzamides and compositions benzamides for use as fungicizide | CYC1, ME3, ME2 | KMT2A 1890/4885MAPK1 2898/4885GAA 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.